Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latte trial of caffeine citrate in late preterm infants
ACTRN12622001344785Phase 3Active, not recruiting
- Sponsor
- The University of Auckland
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in preterm birth and Neurodevelopmental disorder (NDD) comparing Caffeine citrate with Placebo syrup control (2 arms). Primary endpoint: BSID IV cognitive score. Started May 2023; status: active, not recruiting.
02
Drugs
caffeine
03
Conditions
preterm birthNeurodevelopmental disorder (NDD)
Beyond the preview
Go deeper on ACTRN12622001344785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622001344785.